ClinicalTrials.gg
RecruitingNCT05746702Updated Jul 6, 2023

Investigation of Arm Swings Characteristics in Patient With Chronic Obstructive Pulmonary Disease

An observational study in Chronic Obstructive Pulmonary Disease, Postural; Defect and Gait, Unsteady, sponsored by Hacettepe University. Recruiting at 1 site in Turkey. Open to participants aged 40 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-07-06.

Sponsored by Hacettepe University · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 5 months ago, but the record still lists the study as recruiting.
  • Started Mar 2023; still recruiting 3 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
40
Ages
40 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University — 10 open to participants now, 12 under way, none of them phase 3. Pulmonary Disease, Chronic Obstructive · Hacettepe University.

Planned enrollment
8th of 12
40 · median 45
Started
2023
with 1 other
Observational
12 of 18
8 open now
Primary completion
2024-06
later than 0 of 11 live
Registered
5th of 18
by date

Among the 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University, this one is the 8th largest by planned enrollment of the 12 observational ones that give a count, is one of 2 that started in 2023, is one of 12 observational ones, reaches primary completion later than 0 of the 11 other live ones, and was the 5th registered.

Pulmonary Disease, Chronic Obstructive

5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.

Browse Pulmonary Disease, Chronic Obstructive studies →

Open to participants now

10 of the 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University are open now, in 1 country. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Where they have run

Who these studies take

Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.

This study: 40 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Pulmonary Disease, Chronic Obstructive by Hacettepe University, or all of them as a file.
02

Study summary

The former aim of this study is to determine whether the arm swings change in patients with Chronic Obstructive Pulmonary Disease (COPD) according to healthy subjects. The latter purposes to investigate the correlation between balance parameters and arm swing, how to change arm swing according to severity of the disease, and to determine the relationship between balance and the severity of disease, the relationship of posture both arm swing and severity of disease in patients with COPD. In accordance with this purposes, 20 patients with COPD who have Global Initiative for Chronic Obstruction Lung Disease (GOLD) stage 1-2-3 and 20 healthy controls will be included between the ages of 40 and 65, respectively. Tests and questionnaires will be used in order to determine the severity of COPD and to evaluate posture. Berg Balance Scale, Time Up and Go Test, 6 Minute Pegboard and Ring Test, 6 Minute Walk Test and gait analysis will be performed. It is expected that by determining the parameters that can be affected by severity of COPD. It is estimate to have information about severity of the disease by means of observational analysis. It will guide professional working in the field.

03

Conditions studied

  • Chronic Obstructive Pulmonary Disease
  • Postural; Defect
  • Gait, Unsteady
  • Dyspnea
04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients referred by the department of chest diseases of Hacettepe university will be taken.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Who has been clinically stable for the last 4 weeks,
  • who will be able to walk independently for 6 minutes,
  • According to the Classification of Airflow Limitation in (GOLD) system, the Stage is 1-2-3,
  • who declares that he has not taken part in any other research

Exclusion criteria

Exclusion Criteria:

  • walking assistive devices,
  • receiving chronic oxygen therapy,
  • with central and peripheral vestibular disease,
  • with orthopedic, neuromuscular, neurological and cardiac diseases that may affect gait and balance,
  • with a history of lung cancer, sarcoidosis, tuberculosis and/or lung surgery,
  • who has communication problems,
  • with mental and cognitive problems
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
40 participants (estimated)
Target follow-up
7 Days
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Arm Swings Characteristics

    Change of the arm swings during 6 minute gait in patients with Chronic Obstructive Pulmonary Disease according to healthy subjects.

    Time frame: 1 day

Secondary outcomes

  1. Spatiotemporal Characteristic

    Change of the spatiotemporal characteristic during 6 minute gait in patients with Chronic Obstructive Pulmonary Disease according to healthy subjects.

    Time frame: 1 day

  2. Upper Extremity Functional Capacity

    Upper extremity functional capacity by 6 minute pegboard and ring test in patient with Chronic Obstructive Pulmonary Disease

    Time frame: 1 day

  3. Balance

    Balance by Berg Balance Scale and Time Up Go Test in patient with Chronic Obstructive Pulmonary Disease

    Time frame: 1 day

  4. Severity of Disease

    severity of disease by GOLD ( Global İnitiative for Chronic Obstructive Pulmonary Disease) , CAT ( Chronic Respiratory Questionnaire), Pulmonary Function Test in patient with Chronic Obstructive Pulmonary Disease

    Time frame: 1 day

  5. Posture

    posture by Corbin Posture Analyses Form in patient with Chronic Obstructive Pulmonary Disease

    Time frame: 1 day

  6. Functional Exercise Capacity

    Functional exercise capacity by six minute gait test in patients with Chronic Obstructive Pulmonary Disease.

    Time frame: 1 day

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2023 (actual). Primary completion is estimated for Jun 2024, 15 months after the start.

Of 469 non-industry observational studies under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 62. This study's planned 15 months is below that.

Counting every sponsor, half of 589 studies reached it within 26 months; a quarter within 14 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 30, 2023
First posted
Feb 28, 2023
StartActual
Mar 1, 2023
Primary completionEst.
Jun 19, 2024
CompletionEst.
Oct 19, 2024
Last update
Jul 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05746702
Responsible party
Aynur Demirel (PT, PhD, Assoc. Prof., Hacettepe University) — Principal investigator
First posted
Feb 28, 2023
Start date
Mar 1, 2023
Primary completion
Jun 19, 2024 (estimated)
Completion
Oct 19, 2024 (estimated)
Last update
Jul 6, 2023

Study contacts

Aynur Demirel, PhD
Contact
aynur.demirel@hacettepe.edu.tr
+90 3123051576 ext. 178
Aynur Demirel, PhD
principal investigator · Hacettepe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion